Literature DB >> 12185085

Two nonadjacent regions in enteroaggregative Escherichia coli flagellin are required for activation of toll-like receptor 5.

Meghan A Donnelly1, Theodore S Steiner.   

Abstract

Flagellin is the major structural protein of the flagella of Gram-negative bacteria. Recent work has demonstrated that flagellin is a potent trigger of innate immune responses in a number of eukaryotic cells and organisms, including both mammals and plants. In several different human epithelial cell lines, this innate immune response involves toll-like receptor 5 (TLR5). The mechanisms by which flagellin activates TLR5 and the importance of this interaction in other model systems of flagellin-induced inflammation remain unknown. In this work, random and site-directed mutagenesis of the inflammatory flagellin from enteroaggregative Escherichia coli identified two regions in the conserved D1 domain that are required for interleukin-8 release and TLR5 activation. In contrast, large regions of the variable domain could be excised without reducing the inflammatory activity. In addition, regions of the protein analogous to epitopes that trigger innate immune responses in plants are not involved in Caco-2 flagellin responses. These results highlight the complexity of the interaction between bacterial flagellin and its eukaryotic recognition partners and provide the basis for further studies to characterize the innate immune response to flagellin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185085     DOI: 10.1074/jbc.M206851200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.

Authors:  John T Bates; Aaron H Graff; James P Phipps; Jason M Grayson; Steven B Mizel
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

2.  Structural and genetic characterization of glycosylation of type a flagellin in Pseudomonas aeruginosa.

Authors:  M Schirm; S K Arora; A Verma; E Vinogradov; P Thibault; R Ramphal; S M Logan
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

Review 3.  Effects of flagellin on innate and adaptive immunity.

Authors:  Anna N Honko; Steven B Mizel
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.

Authors:  M Chelsea Lane; Virginia Lockatell; Greta Monterosso; Daniel Lamphier; Julia Weinert; J Richard Hebel; David E Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 5.  How flagellin and toll-like receptor 5 contribute to enteric infection.

Authors:  Theodore S Steiner
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 6.  Flagellin as an adjuvant: cellular mechanisms and potential.

Authors:  Steven B Mizel; John T Bates
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

7.  The N terminus of type III secretion needle protein YscF from Yersinia pestis functions to modulate innate immune responses.

Authors:  Patrick Osei-Owusu; Danielle L Jessen Condry; Melody Toosky; William Roughead; David S Bradley; Matthew L Nilles
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

8.  Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.

Authors:  Wei Li; Jingyi Yang; Ejuan Zhang; Maohua Zhong; Yang Xiao; Jie Yu; Dihan Zhou; Yuan Cao; Yi Yang; Yaoming Li; Huimin Yan
Journal:  Cell Mol Immunol       Date:  2015-04-27       Impact factor: 11.530

9.  Structural study of binding of flagellin by Toll-like receptor 5.

Authors:  Saul G Jacchieri; Ricardo Torquato; Ricardo R Brentani
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

10.  Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation.

Authors:  Teresa A Urban; Adam Griffith; Anastasia M Torok; Mark E Smolkin; Jane L Burns; Joanna B Goldberg
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.